红蓝光联合他扎罗汀治疗面部寻常型痤疮60例临床观察

发布时间：2018-06-03 11:14

本文选题：红蓝光 + 他扎罗汀　；参考：《中国皮肤性病学杂志》2015年09期

【摘要】：目的评价红蓝光联合他扎罗汀治疗面部寻常型痤疮的临床效果和安全性。方法将入选的179例寻常型痤疮患者随机分为三组,对照1组(60例)予红蓝光治疗,对照2组(59例)予他扎罗汀治疗,治疗组(60例)予红蓝光联合他扎罗汀治疗,比较三组患者的临床疗效和不良反应。疗程均为8周。结果对照1组、对照2组、治疗组的有效率分别为71.67%,79.66%和95.00%。治疗组的有效率均高于其他两组,差异均有统计学意义(P均0.01)。另外,三组患者的不良反应发生率差异无统计学意义(P0.05)。结论红蓝光联合他扎罗汀治疗面部寻常型痤疮疗效好,不良反应轻。
[Abstract]:Objective to evaluate the efficacy and safety of red and blue light combined with tazarotene in the treatment of facial acne vulgaris. Methods 179 patients with acne vulgaris were randomly divided into three groups: the control group (n = 60) was treated with red and blue light, the control group (n = 59) was treated with tacarotene, and the treatment group (n = 60) was treated with red and blue light combined with tazarotene. The clinical efficacy and adverse reactions of the three groups were compared. The course of treatment was 8 weeks. Results the effective rates of control group 1 and control group 2 were 71.67% and 95.00% respectively. The effective rate in the treatment group was higher than that in the other two groups, and the difference was statistically significant (P < 0.01). In addition, there was no significant difference in the incidence of adverse reactions among the three groups (P 0.05). Conclusion Red and blue light combined with tazarotene is effective in the treatment of facial acne vulgaris.
【作者单位】：重庆医药高等专科学校药学院;重庆市第九人民医院药剂科;
【分类号】：R758.733

【参考文献】